STAT+: Detailed data show Summit therapy beat Merck blockbuster Keytruda in late-stage lung cancer trial
SAN DIEGO — For years, Merck’s drug Keytruda has dominated cancer immunotherapy, racking up dozens…
Author: STAT
Opinion: First Opinion readers on cancer screening, mpox vaccines, and more
First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences…
Missouri resident who had no contact with animals tests positive for bird flu
This is a developing story and will be updated. A person in Missouri who didn’t…
STAT+: Dana-Farber’s Laurie Glimcher is leaving on her own terms. That’s the difference between male and female leadership.
Laurie Glimcher stunned Boston’s medical world last September by orchestrating Dana-Farber Cancer Institute’s breakup with its longtime…
STAT+: Ascension, other hospitals played active roles to take medical billing company R1 RCM private
Private equity firms are leading the buyout of R1 RCM, a major provider of billing…
Transparent mice and using zip codes to predict heart risk
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning…
STAT+: Pharmalittle: We’re reading about FDA inspections, Lilly insulin trial results, and more
And so, another working week will soon draw to a close. Not a moment too…
Opinion: Gaza polio vaccination drive must include measles shots
We have each worked on childhood vaccination programs in both development and humanitarian emergency settings…
Opinion: Presidential debate moderators should ask about mental health policy
As the mom of three young adults, I am worried about their economic future —…
Upending a longstanding paradigm, cardiologists embrace ZIP codes, not race, to predict heart risk
Not only is Joseph Wright a physician, he’s the chief health equity officer for the…
STAT+: Vor Biopharma’s ‘shielded’ transplant delays relapse in leukemia patients
A CRISPR-augmented stem cell transplant that protects healthy cells from the toxic effects of anti-cancer…
In a first, living mice are made transparent
When a dye called tartrazine is added to food, it creates a bright yellow hue…
Summit’s upcoming cancer results, Recursion’s mixed data, and the next big obesity target
How effective is Summit Therapeutics’ lung cancer immunotherapy? Why are obesity drugmakers turning back to…
Youth vaping continues its tumble from a Juul-fueled high
The number of U.S. kids who are using e-cigarettes has continued to tumble, new federal…
STAT+: The battle over race in kidney function equations
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning…
Medicare claims data offer clues on doctors most likely to offer telehealth visits
You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology…
STAT+: U.K. charities give $36 million to start new drugs for childhood tumors
For three decades, adults have benefited from a revolution in oncology treatment, as immunotherapies and…
Nearly 2,000 drug manufacturing plants are overdue for FDA inspections after Covid delays
Federal regulators responsible for the safety of the U.S. drug supply are still struggling to…
Lilly has more positive data on its weekly insulin
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pharmalittle: We’re reading about China detaining AstraZeneca staff, pharma layoffs, and more
Rise and shine, another busy day is on the way. However, this is also shaping…
STAT+: Summit Therapeutics vs. Merck: Prepping for a big lung cancer study reveal
Let’s set the table for Sunday’s presentation of the lung cancer immunotherapy trial known as…
STAT+: Alnylam versus BridgeBio: The ATTR-CM debate
I coined the term “Typo-gate” to describe the misguided dustup Alnylam Pharmaceuticals executives instigated last…
STAT+: Can amylin drugs best Wegovy and Zepbound? Companies bet on next big obesity target
Nearly two decades ago, a small company called Amylin Pharmaceuticals saw that its first commercial…
Opinion: The truth behind that viral study on fluoride and IQ
A version of this essay first appeared in Jess Steier’s newsletter, “Unbiased Science.” Fluoride is…
Opinion: Eight former CDC directors: Hollowing out the CDC is a prescription for disaster
As former directors of the Centers for Disease Control and Prevention, we are deeply concerned…
Inside the bruising battle to purge race from a kidney disease calculator
There it was on James Cannon’s lab report, two tiny words: African American. The words…
STAT+: Humana cutting Medicare Advantage plans that cover 10% of members
Roughly 10% of people enrolled in Humana’s private Medicare plans will have to find new…
Depression: How brain scans helped predict long-term treatment outcomes
Depression has many faces. Some people can’t sleep, while others struggle to get out of…
Birth control vending machines, seasonal shots, and the “Snoo”
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning…
Moderna reports encouraging results on its mpox vaccine, as outbreaks in Africa spread
The emergence of a second mpox outbreak in which the virus is spreading from person…
Study of gender-affirming care reveals immune system sex differences
Researchers have long known that, in general, women are more susceptible to autoimmune disorders than…
STAT+: Pharmalittle: We’re reading about a Vaxcyte vaccine, Ozempic shortages, and more
Hello, everyone, and how are you today? We are doing just fine, thank you, especially…
BioMarin’s big day today
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Novartis to spend $200 million in further bid to boost radiopharma manufacturing, market dominance
Novartis is opening a new manufacturing facility in California and expanding an existing production site…
Trying to time your seasonal vaccines just right? There are no easy answers, but here are some factors to consider
With fall coming into view, public health officials across the country are turning to the…
Birth control has become harder to get. New York has some creative solutions
A typical vending machine on a university campus might offer students the usual range of…
Opinion: The Snoo can’t help the people who need it most
When you have a baby, sleep becomes the holy grail. You become convinced that getting…
How race became ubiquitous in medical decision-making tools
It was created with the best intentions: a government policy asking researchers to collect racial…
STAT+: Drug aimed at strengthening neurons to treat Alzheimer’s fails in trial
A dark horse effort to treat Alzheimer’s disease, already marred by a data manipulation scandal,…
STAT+: Greece’s antitrust regulator probes Novartis over practices tied to a pricey eye drug
Greece’s antitrust regulator is investigating allegations that, over a nine-year period, Novartis paid doctors and…
STAT+: Vaxcyte shares boom as one of biotech’s big David vs. Goliath stories heats up
With new vaccine data released Tuesday, Vaxcyte, a San Carlos, Calif.-based firm, emerged as one…
STAT+: Dana-Farber CEO Laurie Glimcher to step down, saying ‘we must look to the next generation’
Laurie H. Glimcher, chief executive of Dana-Farber Cancer Institute, said she would step down next…
STAT+: Pharmalittle: We’re reading about Medicare drug prices, a Sanofi MS pill, and more
Good morning, everyone, and welcome to another working week. We hope the weekend respite —…
A STAT Investigation: Embedded Bias
Want to stay on top of health news? Sign up to get our Morning Rounds newsletter in…
STAT+: Recursion presents mixed data on lead AI-derived drug candidate for potentially fatal brain condition
Recursion Pharmaceuticals announced results of a clinical trial for its lead drug candidate Tuesday that,…
STAT+: European court sides with Illumina, saying regulators overstepped in scrutiny of Grail deal
LONDON — Europe’s top court on Tuesday ruled that regulators overstepped in challenging the DNA…
Explore the clinical tools that use race to steer care
Every day, physicians use clinical algorithms to make decisions about the patients in their exam…
Doctors use problematic race-based algorithms to guide care every day. Why are they so hard to change?
Pediatrician Alexandra Epee-Bounya had had enough. In her 20 years caring for children in Boston,…
STAT+: Diagnosed with cancer, a pharmaceutical executive became a patient advocate and changed drug development. It took decades
Kathy Giusti was diagnosed with multiple myeloma in 1996, when she was a 37-year-old executive…
Why clinicians are reconsidering race-based algorithms
Algorithms are ubiquitous in medicine. They can take the form of a flowchart, a simple…